NCT01856712View on ClinicalTrials.gov

Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Alcohol Dependence
Interventions
DRUG

Naltrexone

Naltexone was chosen for this study because naltrexone is the only medication available in both oral daily and injectable monthly formulations, which will allow the study to examine issues around medication adherence.

Trial Locations (1)

53715

University of Wisconsin - Department of Family Medicine, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01856712 - Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence | Biotech Hunter | Biotech Hunter